3/9
08:22 am
sgmo
Sangamo Therapeutics Advances Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease [Yahoo! Finance]
Medium
Report
Sangamo Therapeutics Advances Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease [Yahoo! Finance]
3/9
08:05 am
sgmo
Sangamo Therapeutics Advances Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease
Medium
Report
Sangamo Therapeutics Advances Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease
2/10
08:05 am
sgmo
Sangamo Therapeutics (NASDAQ:SGMO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Medium
Report
Sangamo Therapeutics (NASDAQ:SGMO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
2/3
06:05 pm
sgmo
Sangamo Therapeutics Presents Detailed Data from Registrational STAAR Study in Fabry Disease at WORLDSymposium™ 2026 [Yahoo! Finance]
Medium
Report
Sangamo Therapeutics Presents Detailed Data from Registrational STAAR Study in Fabry Disease at WORLDSymposium™ 2026 [Yahoo! Finance]
2/3
04:05 pm
sgmo
Sangamo Therapeutics Presents Detailed Data from Registrational STAAR Study in Fabry Disease at WORLDSymposium™ 2026
Medium
Report
Sangamo Therapeutics Presents Detailed Data from Registrational STAAR Study in Fabry Disease at WORLDSymposium™ 2026
2/3
09:10 am
sgmo
Sangamo Therapeutics Announces Pricing of $25.0 Million Underwritten Offering
High
Report
Sangamo Therapeutics Announces Pricing of $25.0 Million Underwritten Offering
1/31
01:33 am
sgmo
Sangamo Therapeutics (NASDAQ:SGMO) was downgraded by analysts at
Wall St
High
Report
Sangamo Therapeutics (NASDAQ:SGMO) was downgraded by analysts at
Wall St
1/23
07:09 pm
sgmo
How The Pulled Price Target Is Reshaping The Story For Sangamo Therapeutics (SGMO) [Yahoo! Finance]
Low
Report
How The Pulled Price Target Is Reshaping The Story For Sangamo Therapeutics (SGMO) [Yahoo! Finance]
1/12
04:40 am
sgmo
Sangamo Therapeutics (SGMO) Shares Stabilize Amid Recent Key Pipeline Update [Yahoo! Finance]
Low
Report
Sangamo Therapeutics (SGMO) Shares Stabilize Amid Recent Key Pipeline Update [Yahoo! Finance]
1/6
08:17 am
sgmo
Atsena Therapeutics Appoints McDavid Stilwell as Chief Financial Officer [Yahoo! Finance]
Medium
Report
Atsena Therapeutics Appoints McDavid Stilwell as Chief Financial Officer [Yahoo! Finance]
12/18
09:05 am
sgmo
Sangamo Therapeutics Initiates Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease [Yahoo! Finance]
Medium
Report
Sangamo Therapeutics Initiates Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease [Yahoo! Finance]
12/18
08:05 am
sgmo
Sangamo Therapeutics Initiates Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease
Low
Report
Sangamo Therapeutics Initiates Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease